Highlights Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2026 BST			5-day change	1st Jan Change
56.39 ^USD	-5.97%		-4.25%	+19.70%

06-04	Bruker Corporation Showcases Expanding Microbiology and Infection Diagnostics Portfolio at ASM Microbe 2026	CI
06-02	Bruker Corporation Launches New Timsmrms Mass Spectrometry Platform for Ultra-Complex Mixture Applications in the Energy Industry	CI

Highlights

06-04	Bruker Corporation Showcases Expanding Microbiology and Infection Diagnostics Portfolio at ASM Microbe 2026	CI
06-02	Bruker Corporation Launches New Timsmrms Mass Spectrometry Platform for Ultra-Complex Mixture Applications in the Energy Industry	CI
06-01	Bruker Corporation Launches Novel Mass Spectrometry Systems and Advances in 4D Proteomics and Metabolomics	CI
05-26	Bruker Corporation Commissions Novel Biospec 18 Tesla Preclinical Mri At Champalimaud Foundation	CI
05-13	Bruker Corporation announces Quarterly dividend, payable on July 07, 2026	CI
05-06	Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook	MT
05-06	(BRKR) Bruker Expects 2026 Revenue Range $3.57B - $3.6B, vs. FactSet Est of $3.58B	MT
05-06	(BRKR) Bruker Expects 2026 Adjusted EPS Range $2.10 - $2.15, vs. FactSet Est of $2.11	MT
05-06	Earnings Flash (BRKR) Bruker Corporation Reports Q1 Revenue $823.4M, vs. FactSet Est of $795.6M	MT
05-06	Earnings Flash (BRKR) Bruker Corporation Posts Q1 Adjusted EPS $0.31 per Share, vs. FactSet Est of $0.23	MT
05-06	Bruker Corporation Reconfirms Earnings Guidance for the Fiscal Year 2026	CI
05-06	Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-17	Bruker Corporation Expands Maldi Biotyper and IR Biotyper Workflows for Microbial Identification and Outbreak Management	CI
04-17	Bruker Microbiology & Infection Diagnostics Division Launches Mygenius Pro High-Throughput Sample-To-Answer Molecular Diagnostics System	CI
04-17	Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe	MT
04-13	Bruker Corporation Unveils New NMR Products And Workflow Solutions	CI
04-07	Bruker Corporation Accelerates Development of Photothermal Afm-Ir Spectroscopy Capabilities	CI
04-07	Bruker Collaborates With Imec to Expand NanoIR Spectroscopy Into Semiconductor Research	MT
03-31	Bruker, Seer Each Claim Partial Win in US Patent Board Ruling	MT
03-31	Biognosys AG says PTAB revokes central claims of U.S. patent no. 11,435,360	RE
03-22		FA
02-25	Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of Cellscape Xr	CI
02-24	Bruker Spatial Biology Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications	CI
02-23	Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum	CI
02-23	Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum	CI